1. Home
  2. SIDU vs KZIA Comparison

SIDU vs KZIA Comparison

Compare SIDU & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sidus Space Inc.

SIDU

Sidus Space Inc.

N/A

Current Price

$0.94

Market Cap

110.3M

ML Signal

N/A

Logo Kazia Therapeutics Limited

KZIA

Kazia Therapeutics Limited

N/A

Current Price

$6.54

Market Cap

125.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SIDU
KZIA
Founded
2012
1994
Country
United States
Australia
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.3M
125.6M
IPO Year
2021
2002

Fundamental Metrics

Financial Performance
Metric
SIDU
KZIA
Price
$0.94
$6.54
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $28.76
AVG Volume (30 Days)
★ 3.6M
173.7K
Earning Date
11-24-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 66.94
N/A
EPS
N/A
★ N/A
Revenue
★ $3,383,878.00
N/A
Revenue This Year
$165.97
N/A
Revenue Next Year
$455.56
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.63
$4.86
52 Week High
$6.79
$17.40

Technical Indicators

Market Signals
Indicator
SIDU
KZIA
Relative Strength Index (RSI) 30.91 32.56
Support Level $0.88 $4.86
Resistance Level $1.25 $14.85
Average True Range (ATR) 0.11 0.66
MACD 0.02 -0.02
Stochastic Oscillator 14.05 14.94

Price Performance

Historical Comparison
SIDU
KZIA

About SIDU Sidus Space Inc.

Sidus Space Inc is a space and defense technology company with core capabilities that include dual use satellite manufacturing & technology integration, AI products and services, space and defense hardware components and space-based data solutions. The company generates revenue through a combination of: Satellite platform sales and customization, Payload hosting and mission services, Engineering and systems integration services, and Space and defense hardware manufacturing. The firm supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers. The firm generates revenue principally from satellite platform and payload hosting contracts, manufacturing and engineering services, mission operations, and sales of proprietary hardware products.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.

Share on Social Networks: